Industry

Partnership will bring new artificial intelligence threat detection capabilities to Analogic’s growing installed base of ConneCT Checkpoint and SeleCT Checked Baggage Computed Tomography (CT) systems PEABODY, Mass.–(BUSINESS WIRE)–Analogic Corporation, a world leader in imaging and detection solutions for aviation security and healthcare markets, and Analytical AI, a pioneer in artificial intelligence (AI) and machine learning … [Read more…]

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it has been selected to deliver a late-breaking oral presentation at the Liver Meeting® 2025. The oral presentation will feature new … [Read more…]

MATAWAN, N.J. & EUGENE, Ore.–(BUSINESS WIRE)–Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (“Apimeds”) today announced the expansion of the Apimeds ai² Futures Lab program through a new collaboration with the University of Oregon’s Lundquist College of Business, starting with the Winter 2026 quarter. The initiative connects student teams with real-world biopharma business development projects, reinforcing Apimeds’ … [Read more…]

The event will provide clinical perspectives and market outlook for lacutamab, Innate’s lead proprietary product progressing towards potential accelerated approval in SS and confirmatory phase 3 initiation Leading KOL Pierluigi Porcu, M.D., a world expert in T-cell lymphomas, will discuss results from the TELLOMAK Phase 2 trial ZS Associates, leading experts in life sciences and … [Read more…]

HONG KONG–(BUSINESS WIRE)–Pacific Prime, a global health insurance brokerage, employee benefits, and risks specialist, is proud to announce the 2025 edition of the State of Health Insurance (SOHI) Report. The report captures the trends shaping the global health insurance landscape and responses from the insurance and business sectors. Download your 2025 State of Health Insurance … [Read more…]

(Securities Code: 4967 JT) *The first shareholder derivative lawsuit hearing takes place today at Osaka District Court *Oasis seeks to hold directors accountable for the Beni-Koji incident and to help Kobayashi Pharma recover damages caused to it by the directors at the time of the incident More information available at www.KobayashiCorpGov.com HONG KONG–(BUSINESS WIRE)–Oasis Management … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Sleep Apnea Devices Market by Product (Therapeutic (PAP (CPAP, APAP, BPAP), Oral Appliances, Masks), Diagnostic (PSG, Home Sleep Testing, Oximeter)), Age, Gender, End User (Sleep Clinics, Hospitals, Home Care Settings) – Global Forecast to 2032” has been added to ResearchAndMarkets.com’s offering. The sleep apnea devices market is gaining significant momentum, estimated at USD … [Read more…]

New collaboration introduces the Press Ganey Clinical Operating System (cOS) to support safer, higher-quality care, and enhanced human experience GREENVILLE, S.C.–(BUSINESS WIRE)–Press Ganey, the leader in experience measurement, analytics, and advisory services for health systems and health plans, today announced a strategic partnership with Prisma Health. The collaboration aims to transform healthcare operations with a … [Read more…]

Dallas-Based 5IR Funds Leads Investment in AI-First Company DALLAS & CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–#AI–5IR Funds, a venture fund backing foundational technologies of the Fifth Industrial Revolution, today announced it is leading a $6.5 million Series A investment in HOOTL, an AI-first company building secure, scalable automation to fix one of healthcare’s most broken systems: insurance processing. … [Read more…]

Back-to-back Presidential Symposium presentations of ENHERTU from DESTINY-Breast11 and DESTINY-Breast05 demonstrate its potential to become a foundational treatment in curative-intent settings of HER2 positive early breast cancer Late-breaking data from TROPION-Breast02 showcase that DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy as first-line treatment for patients with first-line metastatic … [Read more…]